Hanne Damgaard Jensen

Chief Operating Officer at CURASIGHT A/S

Net worth: 6 292 $ as of 2024-03-30

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Jan van de Winkel	M	63	GENMAB A/S	25 years
Andreas Kjaer	M	61	CURASIGHT A/S	11 years
Ulrich Krasilnikoff	M	57	CURASIGHT A/S	8 years
Carsten Nielsen	M	41	CURASIGHT A/S	11 years
Per Falholt	M	65	CURASIGHT A/S	4 years
Jacob Madsen	M	52	CURASIGHT A/S	11 years
Henrik Ehlers Wulff	M	54	NOVO NORDISK A/S	25 years
Karsten Munk Knudsen	M	53	NOVO NORDISK A/S	25 years
Charlotte Vedel	M	56	CURASIGHT A/S	4 years
Anthony Pagano	M	46	GENMAB A/S	17 years
Lars Trolle	M	57	CURASIGHT A/S	10 years
Martine van Vugt	M	71	GENMAB A/S	23 years
Camilla Sylvest	F	52	NOVO NORDISK A/S	28 years
Anders Gersel Pedersen	M	73	GENMAB A/S	21 years
Birgitte Stephensen	F	63	GENMAB A/S	22 years
Kirsten Drejer	M	68	CURASIGHT A/S	3 years
Nic Gillings	M	56	CURASIGHT A/S	-

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Michael Blair Widmer	M	76	GENMAB A/S	11 years
Bo Kruse	M	52	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. GENMAB A/S	15 years
Jakob Riis	M	58	NOVO NORDISK A/S	21 years
Claus Juan Møller-San Pedro	M	62	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. GENMAB A/S	21 years
Ole Baadsgaard	M	72	GENMAB A/S	-
Christina Hahner	F	-	GENMAB A/S	-
Jesper Brandgaard	M	60	NOVO NORDISK A/S	20 years
Karsten Havkrog Pedersen	M	74	GENMAB A/S	11 years
David Kauffmann	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	5 years
Burt Malkiel	M	90	GENMAB A/S	11 years
Tom Vink	M	61	GENMAB A/S	-
Nedjad Losic	M	54	GENMAB A/S	-
Lisa N. Drakeman	M	70	GENMAB A/S	11 years
Michael K. Bauer	M	60	GENMAB A/S	14 years
Hans Henrik Munch-Jensen	M	64	GENMAB A/S	8 years
Patrick Loustau	M	61	NOVO NORDISK A/S	14 years
Christopher Yallop	M	-	NOVO NORDISK A/S	6 years
Henrik Poulsen	M	57	NOVO NORDISK A/S	1 years
Martin Olin	M	55	NOVO NORDISK A/S	4 years
Per Gullestrup	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	9 years
Jan Mikkelsen	M	65	NOVO NORDISK A/S	11 years
Jens Munch-Hansen	M	69	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	9 years
Annette Stube	F	57	NOVO NORDISK A/S	11 years
René Djurup	M	-	NOVO NORDISK A/S	4 years
Rikke Glahn Ren	F	-	GENMAB A/S	-
Jorgen Petersen	M	-	GENMAB A/S	-
Patrick van Berkel	M	55	GENMAB A/S	9 years
Anna Héléne Barnekow	F	60	NOVO NORDISK A/S	2 years
Gitte L. Pedersen	F	61	NOVO NORDISK A/S	10 years
Zaiton binti Jamaluddin	F	65	NOVO NORDISK A/S	8 years
Wolfgang Amann	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	-
Peter Nordkild	M	69	NOVO NORDISK A/S	2 years
Joseph Fred Yospe	M	66	GENMAB A/S	2 years
Paul W. H. I. Parren	M	60	GENMAB A/S	16 years
Christian Hansen	M	58	NOVO NORDISK A/S	7 years
Anker Gunvald Lundemose	M	63	NOVO NORDISK A/S	4 years
Peter David Suzdak	M	65	NOVO NORDISK A/S	7 years
Donald Lee Drakeman	M	70	GENMAB A/S	-
Jan Ulf Sigvar J. Johansson	M	79	NOVO NORDISK A/S	7 years
Bruce Carter	M	80	NOVO NORDISK A/S	4 years
Jan Öhrström	M	67	NOVO NORDISK A/S	9 years
Peter James Arthur Benson	M	69	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	2 years
Bo Jesper Hansen	M	66	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	5 years
Christian Gröndahl	M	60	NOVO NORDISK A/S	14 years
Annarie Lyles	M	63	GENMAB A/S	-
Florian Schönharting	M	55	GENMAB A/S	-
Jens Jesper Ovesen	M	67	NOVO NORDISK A/S	4 years
Finn M. Ulrich	M	-	NOVO NORDISK A/S	8 years
Per Toft Valstorp	M	75	NOVO NORDISK A/S	14 years
Michael Wolff Jensen	M	53	GENMAB A/S	3 years
Thomas Feldthus	M	64	NOVO NORDISK A/S	3 years
Valeta A. Gregg	M	72	NOVO NORDISK A/S	5 years
Peder Holk Nielsen	M	67	NOVO NORDISK A/S	5 years
Jette Traulsen	M	-	NOVO NORDISK A/S	5 years
Joan Schmidt	F	60	NOVO NORDISK A/S	20 years

Statistics

Country	Connections	% of total
Denmark	72	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections